dansyl phosphatidylethanolamine has been researched along with Hyperlipoproteinemia Type IV in 1 studies
*Hyperlipoproteinemia Type IV: A hypertriglyceridemia disorder, often with autosomal dominant inheritance. It is characterized by the persistent elevations of plasma TRIGLYCERIDES, endogenously synthesized and contained predominantly in VERY-LOW-DENSITY LIPOPROTEINS (pre-beta lipoproteins). In contrast, the plasma CHOLESTEROL and PHOSPHOLIPIDS usually remain within normal limits. [MeSH]
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Glueck, CJ; Jackson, RL; Johnson, JD; Kashyap, ML; Shirai, K; Taskinen, MR | 1 |
1 other study(ies) available for dansyl phosphatidylethanolamine and Hyperlipoproteinemia Type IV
| Article | Year |
|---|---|
Catabolism of human very low density lipoproteins in vitro: a fluorescent phospholipid method for monitoring lipolysis.
Topics: Adult; Animals; Cattle; Dansyl Compounds; Dose-Response Relationship, Drug; Female; Fluorescent Dyes; Humans; Hyperlipoproteinemia Type IV; In Vitro Techniques; Lipolysis; Lipoprotein Lipase; Lipoproteins, VLDL; Male; Methods; Middle Aged; Phosphatidylethanolamines | 1981 |